Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 413-110-2 | CAS number: 135861-56-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 14.3 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 358.3 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- No experimental data available for the inhalation route.
- AF for dose response relationship:
- 1
- Justification:
- Experimental data show reliable dose-response relationship
- AF for differences in duration of exposure:
- 2
- Justification:
- Sub-chronic to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Rat to human correction undertaken during route-to route extrapolation of starting dose
- AF for other interspecies differences:
- 2.5
- Justification:
- Standard default value in ECHA guidance.
- AF for intraspecies differences:
- 5
- Justification:
- Standard default value in ECHA guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Data base is good
- AF for remaining uncertainties:
- 1
- Justification:
- No other uncertainties apparent
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.1 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 406.4 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- No experimental data available for the repeated dose dermal route.
- AF for dose response relationship:
- 1
- Justification:
- Experimental data show reliable dose-response relationship.
- AF for differences in duration of exposure:
- 2
- Justification:
- Sub-chronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Rat to human extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- Standard default value in ECHA guidance.
- AF for intraspecies differences:
- 5
- Justification:
- Standard default value in ECHA guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Data base is good
- AF for remaining uncertainties:
- 1
- Justification:
- No other uncertainties apparent
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
The DNEL for long-term inhalation exposure was derived from a NOAEL of 406.4 mg/kg bw/day for a sub-chronic dietary toxicity study in rats (Pharmakon Europe, 1993) . The corrected starting dose was calculated using the formula 406.4 mg/kg bw/day x 1/0.38 (rat standard breathing volume) x 0.5 (absorption differences) x 6.7/10 0 (light worker activity) = 358.3. mg/m3. An overall assessment factor of 25 was calculated, based on the ECHA guidance in R8, Figure R-6, May 2008, giving a DNEL of 14.3 mg/m3.
The DNEL for long-term dermal exposure was derived from a NOAEL of 406.4 mg/kg bw/day for a sub-chronic oral toxicity study in rats (Pharmakon Europe, 1993). The corrected starting dose was calculated using the formula 406.4 mg/kg bw/day x 1 (absorption difference) = 406.5 mg/kg bw/day. An allometric scaling factor of 4 was used (rat to human) and an overall assessment factor of 100 was calculated, based on the ECHA guidance in R8, Figure R-6, May 2008, giving a DNEL of 4.1 mg/kg bw/day.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 176.7 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- No experimental data available for the inhalation route.
- AF for dose response relationship:
- 1
- Justification:
- Experimental data show reliable dose-response relationship
- AF for differences in duration of exposure:
- 2
- Justification:
- Sub-chronic to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Rat to human correction undertaken during route-to route extrapolation of starting dose
- AF for other interspecies differences:
- 2.5
- Justification:
- Standard default value in ECHA guidance.
- AF for intraspecies differences:
- 10
- Justification:
- Standard default value in ECHA guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Data base is good
- AF for remaining uncertainties:
- 1
- Justification:
- No other uncertainties apparent
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 406.4 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- No experimental data available for the dermal route.
- AF for dose response relationship:
- 1
- Justification:
- Experimental data show reliable dose-response relationship
- AF for differences in duration of exposure:
- 2
- Justification:
- Sub-chronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Rat to human extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- Standard default value in ECHA guidance.
- AF for intraspecies differences:
- 10
- Justification:
- Standard default value in ECHA guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Data base is good
- AF for remaining uncertainties:
- 1
- Justification:
- No other uncertainties apparent
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 406.4 ng/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Experimental data show reliable dose-response relationship
- AF for differences in duration of exposure:
- 2
- Justification:
- Sub-chronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Rat to human extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- Standard default value in ECHA guidance.
- AF for intraspecies differences:
- 10
- Justification:
- Standard default value in ECHA guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Data base is good
- AF for remaining uncertainties:
- 1
- Justification:
- No other uncertainties apparent
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
The DNEL for long-term inhalation exposure was derived from a NOAEL of 406.5 mg/kg bw/day from a sub-chronic dietary toxicity study in rats (Pharmakon Europe, 1993). The corrected starting dose was calculated using the formula 406.4 mg/kg bw/day x 1/1.15 (rat standard breathing volume) x 0.5 (absorption differences) = 176.7 mg/m3. An overall assessment factor of 50 was calculated, based on the ECHA guidance given in R8, Figure R-6, May 2008, giving a DNEL of 3.5 mg/m3.
The DNEL for long-term dermal exposure was derived from a NOAEL of 406.5 mg/kg bw/day from a sub-chronic oral toxicity study in rats (Pharmakon Europe, 1993). The corrected starting dose was calculated using the formula 406.4 mg/kg bw/day x 1 (absorption difference) = 406.5 mg/kg bw/day. An allometric scaling factor of 4 was used (rat to human) and an overall assessment factor of 200 was calculated, based on the ECHA guidance given in R8, Figure R-6, May 2008, giving a DNEL of 2.0 mg/kg bw/day.
The DNEL for long-term oral exposure was derived from a NOAEL of 406.4 mg/kg bw/day from a sub-chronic dietary toxicity study in rats (Pharmakon Europe, 1993). Using an allometirc scaling factor of 4 (rat to human) and overall assessment factor of 200 was calculated, based on the ECHA guidance given in R8, Figure R-6, May 2008, giving a DNEL of 2.0 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.